Browse by Series:

Ramucirumab Approval Expanded, Breakthrough Designation for Crizotinib, and More

Laura Jones
Published: Saturday, May 02, 2015

SELECTED
LANGUAGE
Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Year in Review™: Reflecting on Recent Evidence With an Eye to the Future of Lung Cancer ManagementMar 30, 20191.5
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x